Skip to content

Living Successfully With Chronic Eye Diseases

Living Successfully With Chronic Eye Diseases: the 'Living Successfully With Low Vision' (LSLV) Program - a Randomized Controlled Trial of a Self-management Program for Low Vision

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01879501
Acronym
ADAPT-LAH
Enrollment
160
Registered
2013-06-17
Start date
2013-01-31
Completion date
2015-01-31
Last updated
2013-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related Macular Degeneration, Chronic Diseases, Diabetic Retinopathy, Glaucoma, Low Vision

Keywords

Low vision, Self management, Randomized controlled trial, Quality of life, Self efficacy, Effectiveness, Chronic eye diseases management

Brief summary

The need for low vision services (LVS) will increase exponentially over the coming years due to the anticipated and exponential growth in the ageing population in Singapore and a rise in chronic non-communicable eye diseases. Finding the best evidenced-based management for chronic eye diseases contributing to low vision (LV) is therefore crucial. Improving patient responsibility is the key to managing LV effectively.1 This means achieving optimum self management (SM).2 However, there are currently no LV SM programs in Singapore and none has been evaluated using a randomized controlled trial (RCT) design, the gold standard methods to evaluate health interventions. The aims of this study are to assess the effectiveness of the 'Living Successfully with Low Vision (LSLV)' program in improving quality of life (QoL) in 160 elderly people with LV attending the Singapore National Eye Centre (SNEC) LV clinic. Of these, 80 will be randomly allocated to receive the LSLV 4-week SM program while the remaining 80 will receive the usual care. Comparisons will be made to determine the efficacy of the LSLV program. QoL, self-efficacy, emotional well being, and vision-specific distress will be assessed 2 weeks after training, and at six months and 12 months post intervention. This study will be the first evidenced-based RCT investigating the effectiveness of a novel vision-specific self-management strategy to improve QoL. It will also adopt a longitudinal design where the effectiveness of these interventions will be evaluated at 12 months-the first follow-up assessment of that duration at both national and international levels. Furthermore this will be the first study to characterize and profile the patients where the effect of the program did not demonstrate an improvement in both primary and secondary outcomes six months after its completion. The future clinical implications of this study include the potential to implement a successful model of LV rehabilitation in other tertiary centres around the country.

Detailed description

The need for low vision services (LVS) will increase exponentially over the coming years due to the anticipated and exponential growth in the ageing population in Singapore and a rise in chronic non-communicable eye diseases. Finding the best evidenced-based management for chronic eye diseases contributing to low vision (LV) is therefore crucial. Improving patient responsibility is the key to managing LV effectively.1 This means achieving optimum self management (SM).2 However, there are currently no LV SM programs in Singapore and none has been evaluated using a randomized controlled trial (RCT) design, the gold standard methods to evaluate health interventions.

Interventions

BEHAVIORALLow Vision Self-Management Program

The program has been describe above.

Sponsors

Ministry of Health, Singapore
CollaboratorOTHER_GOV
University of Melbourne
CollaboratorOTHER
Singapore National Eye Centre
CollaboratorOTHER_GOV
Curtin University
CollaboratorOTHER
Singapore Eye Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 45 years to 75 years * Visual acuity ≤6/12 to ≤6/480 in the better eye after best correction OR * Visual field of less than 10 degrees from the point of fixation, but with the potential to use vision for the planning and/or execution of a task * Duration of low vision ≥ 2 years * No cognitive impairment (as assessed with the 6-item cognitive impairment test) * Have adequate hearing with/without aids to respond to normal conversation

Exclusion criteria

* Not matching the above

Design outcomes

Primary

MeasureTime frame
Vision-related quality of lifeup to 12 months post intervention

Secondary

MeasureTime frame
Perceived self-efficacy, emotional well being, and vision-specific distressbaseline (before randomization to either usual care or intervention group); 2 weeks, 6 months and 12 months post intervention

Countries

Singapore

Contacts

Primary ContactPeggy Chiang, PhD
peggy.chiang.p.c@seri.com.sg+6598548096
Backup ContactChye Fong Peck
peck.chye.fong@seri.com.sg+6593382666

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026